+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Glenmark Life Sciences IPO: How to check allotment status, listing date and more

Aug 3, 2021, 06:30 IST
BCCL
  • Glenmark Life Sciences is likely to announce its share allotment status on August 3.
  • The issue size of the speciality chemical manufacturer was subscribed 45.08 times on the third and final day of the issue on July 29.
  • The company’s IPO has received bids for 66.33 crore equity shares against the IPO size of 1.4 crore equity shares.
  • Check out the latest news and updates on Business Insider.
Advertisement
The public issue of Glenmark Pharmaceuticals’ subsidiary Glenmark Life Sciences is likely to announce its share allotment status for its initial public offering (IPO) on August 3.

Here is how to check Glenmark Life Sciences IPO allotment status on stock exchange website:

  • Go to the BSE website or NSE website here.
  • On BSE, Select 'Equity' and then from the dropdown, select 'Glenmark Life Sciences ‘.
  • Now, enter your application number and PAN.
  • Click on 'Search'.
  • Please note the details will only be available once the shares are allotted.
You can also visit the registrar website (Link Intime India) to check your application status.

  • Visit the registrar's website here.
  • Click on 'Select company' and click on ‘Glenmark Life Sciences ’.
  • Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.
  • Enter the captcha and click ’submit’.
Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you.

Glenmark Life Sciences was looking to raise ₹1,060 crore through the IPO. From the overall IPO proceeds, ₹800 crore will go to the promoter Glenmark Pharmaceuticals as payment for the spin-off. In 2019, the API manufacturing business of Glenmark was spun off into Glenmark Life Sciences as part of a broader reorganisation focusing on the API business.

Advertisement

The IPO was open for subscription from July 27 to July 29 with a price band of ₹695 to ₹720.

The IPO received good demand from investors given it subscribed 45.08 times on the third and final day of the issue. It received bids for 66.33 crore equity shares against the IPO size of 1.4 crore equity shares.

SEE ALSO: ₹10,000 invested in IRCTC shares on listing is worth more than ₹38,000 today ⁠— the record could get even better

India’s largest home loan provider HDFC has given real estate stocks another reason to rally
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article